Learning through patient cases brings realism to practice. This activity gives you the opportunity to learn more about disease burden, quality of life, and cost of care for patients requiring long-term anticoagulation therapy. You will have an opportunity to sharpen your skills in patient education and learn tips for closely monitoring safety and efficacy. You will also discuss potential interactions and working with prescribers to solve drug-related problems. This presentation is intended to help pharmacist clinicians improve their confidence and ability to inform decisions regarding anticoagulation therapy to optimize patient outcomes.
At the completion of this knowledge-based activity, pharmacists will be able to:
- Analyze anticoagulation therapy for appropriateness based on indication, patient-specific comorbidities, ease of use, and cost of care.
- Develop an evidence-based care plan in counseling and monitoring for a patient requiring long-term anticoagulation therapy.
- Identify patients who are at high risk for adverse events associated with anticoagulation therapy and identify strategies for managing these patients.
- Craft an approach to assess and mitigate drug–drug (including prescription, supplement, and herbal therapies) and drug–disease state interactions that can impact the safety and efficacy of anticoagulation therapy.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1.5 contact hours of CPE credit (0.15 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-027-H01-P
To obtain credit for Sharpening the Saw to Mitigate Bleeding: A Case-Based Approach to Anticoagulation Therapy participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation, and then CLAIM credit. Participants need to have a valid pharmacist.com and CPE Monitor/NABP ID account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education assessment. Please note that you will not be permitted to submit the assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.Initial release date: March 12, 2021
Expiration date: March 12, 2024 - No credit granted after this date
Development and Support
Sharpening the Saw to Mitigate Bleeding: A Case-Based Approach to Anticoagulation Therapy is an activity for pharmacists developed by the American Pharmacists Association. This activity is supported by an independent educational grant from the Bristol-Myers Squibb and Pfizer Alliance. © 2021 American Pharmacists Association
Speaker disclosures will be provided at the time of the seminar, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA2021 Virtual Education package. This activity is part of the Trending Topics in Ambulatory Care series.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-21-027-H01-P||0.15 CEUs||March 12, 2021 - March 12, 2024|